Rankings
Pricing
Log In
Free Trial
US-listed companies
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc.
ARQT
Market cap
$970.07M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2023
Product
29
Other revenue
30
Total revenues
60
Cost of sales
5
Research and development
111
Selling, general and administrative
185
Total operating expenses
301
Loss from operations
-241
Other income, net
12
Interest expense
30
Loss before income taxes
-259
Provision for income taxes
3
Net loss
-262
Unrealized loss on marketable securities
1
Foreign currency translation adjustment
-0
Total other comprehensive income (loss)
1
Comprehensive loss
-261
Earnings Per Share, Basic
-3.78
Earnings Per Share, Diluted
-3.78